Regional differences in long-term mortality among hospital-treated asthma and COPD patients

Scandinavian Journal of Public Health

Volumn 25, Issue 4, 1997, Pages 238-242

  Tuuponen, Tuili ^a   Keistinen, Timo ^a   Kiveläa, Sirkka Liisa ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

ageing population; chronic obstructive pulmonary diseases; economic; national health problem; survival; treatment practice; treatment recommendation

Indexed keywords

ANTIASTHMATIC AGENT;

ADULT; ARTICLE; ASTHMA; ATTITUDE; BIOSTATISTICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FINLAND; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTER; SMOKING; SURVIVAL RATE;

EID: 26844485930     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/140349489702500403     Document Type: Article

References (17)

1. Thorn T. International comparisons in COPD mortality. Am Rev Respir Dis 1989; 140: S27-S34.
2. Peto R., Lopez A.D., Boreham J., Thun M., Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339:1268-1278.
3. Hyndman S., Williams D.R., Merrill S.L., Lipscombe J.M., Palmer C.R. Rates of admission to hospital for asthma. BMJ 1994; 308: 1596-1600.
4. Burrows B. The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago ‘COPD’ series. Am Rev Respir Dis 1989; 140: S92-S94.
5. Sutherland J., Persky V.W., Brody J.A. Proportionate mortality trends: 1950 through 1986. JAMA 1990; 1: 1041-4.
6. Siafakas N., Vermeire P., Pride N.R., Paoletti P., Gibson J., Howard P., Yernault J.C., Decramer M., Higenbottam T., Postma D.S., Rees J. Optimal assesment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
7. Bartolome R., Snider G.L., Heflher J., Tiep B., Ziment I., Make B., Braman S., Olsen G., Philips Y. American Thoracic Society Statement. Standards for Diagnosis and Care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 77-120.
8. Klaukka T., Peura S., Martikainen J. Why has utilization of antiasthmatics increased in Finland? J Clin Epidemiol 1991; 44: 859-863.
9. Tuuponen T., Keistinen T., Kivelä S.-L. Regional distribution of asthma-related hospital treatment periods in Finland in 1972–86. Allergy 1993; 48: 353-357.
10. Keskimaki I., Aro S. Accuracy of data diagnoses, procedures and accidents in Finnish Hospital Discharge Register. Int J Health Sciences 1991; 2: 15-21.
11. Osborne M., Vollmer W.M., Buist A.S. Periodicity of asthma, emphysema, and chronic bronchitis in a Northwest Health Maintenance Organisation. Chest 1996; 110:458-462.
12. Rahkonen O., Berg M-A, Puska P. The development of smoking in Finland from 1978 to 1990. British Journal of Addiction 1992; 87: 103-110.
13. Burney P.G.J., Papacosta A.O., Withey C.H., Colley J.R., Holland W.W. Hospital admission rates and the prevalence of asthma symptoms in 20 local authority districts. Thorax 1991; 46: 574-579.
14. Haahtela T., Järvinen M., Kava Tym. Comparison of beta2-agonist, terbutaline, with an inhaled corticosteroid, budenoside, in newly detected asthma. N Engl J Med 1991; 325: 388-392.
15. Haahtela T., Järvinen M., Kava T ym. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331; 700-5.
16. Weinberger M., Oddone E.Z., Henderson W.G. Does increased access to primary care reduce hospital admissions? Engl J Med 1996; 334: 1441-7.
17. Lange P., Ulrik C.S., Vestbo J. Mortality in adults with self-reported asthma. Lancet 1996; 347: 1285-1289.